ABSTRACT 2
of the vastus medialis and vastus lateralis in individuals with and without PFJ OA. 8
Methods 10
Twenty-two participants with PFJ OA and 11 controls aged ≥ 40 yrs were recruited from the community and practitioner referrals. Muscle volumes of individual quadriceps components 12
were measured from thigh magnetic resonance (MR) images. The CSA of the vastus medialis and lateralis were measured at 10 equally distributed levels (femoral condyles to lesser 14 femoral trochanter).
16

Results
PFJ OA individuals had smaller normalized vastus medialis (mean difference 0.90 cm 3 .kg -1 , 18 α=0.011), vastus lateralis (1.50 cm 3 .kg -1 , α=0.012) and rectus femoris (0.71 cm 3 .kg -1 , α=0.009) volumes than controls. No differences in the VM/VL ratio were observed. The CSA 20 at the 3 rd level (controls) and 4 th level (PFJ OA) above the femoral condyles best predicted vastus medialis volume, whereas the vastus lateralis volume was best predicted by the CSA at 22 the 7 th level (controls) and 6 th level (PFJ OA) above the femoral condyles.
INTRODUCTION 2
The patellofemoral joint (PFJ) is the compartment most commonly affected in symptomatic knee osteoarthritis (OA) 1 and is the dominant source of symptoms associated with knee 4 OA 2, 3 .Contemporary clinical guidelines recommend tailored OA management strategies to optimize clinical outcomes, yet there is little known about modifiable impairments that could 6 guide effective management of PFJ OA. Quadriceps weakness plays an important role in the pathogenesis of knee OA 4 and appears to be more important in the progression of PFJ disease 8 than tibiofemoral joint (TFJ) disease 5 . Dynamometry provides an indication of the force produced by the entire quadriceps; however, the limitations of this technique include an 10 inability to evaluate contributions of the individual quadriceps subregions. This may be important for PFJ OA, since imbalance of the medial (vastus medialis) and lateral (vastus 12 lateralis) quadriceps force may affect PFJ alignment 6 and hence PFJ contact pressure 7 .
Considering that increased PFJ contact pressure is likely to be associated with the initiation 14 and progression of PFJ OA, an imbalance in the force generating capacity of the medial and lateral vasti in people with PFJ OA may be a potentially modifiable factor associated with the 16 development or progression of PFJ OA.
18
Magnetic resonance (MR) imaging is one technique that is capable of evaluating the force generating capacity of the individual vasti components. While measurement of muscle cross-20 sectional area (CSA) from MR imaging is gaining popularity as a surrogate measure of individual vasti muscle strength [8] [9] [10] , more meaningful information may be obtained from 22 measures of muscle volume. A muscle's force generating capacity, sometimes also referred to as peak isometric muscle strength or peak isometric force 11 , is related to its volume and its 24 physiological cross sectional area (PCSA) 12 . However, prior studies [8] [9] [10] obtained anatomical
CSAs of muscles at various levels that may not be representative of the muscles' PCSAs. In a 26 5 pennate muscle, the anatomical CSA does not account for angle of muscle pennation or 2 muscle fiber length and hence, may not be a true representative of muscle force. The CSA level of a muscle that has a strong correlation with the muscle's volume should provide an 4 indication of the muscle's strength. The CSA at this level would provide a measurement that could be used to estimate peak isometric muscle force, and would negate the necessity to 6 measure the entire muscle volume using MR, which can be expensive and time consuming. 
14
MATERIALS AND METHODS
Participants 16
Twenty-two participants with PFJ OA (symptomatic and radiographic) and 11 controls (asymptomatic and no radiographic OA) ≥ 40 years of age were recruited for the study. The 18 PFJ OA eligibility criteria were based on a previous study protocol 13 . Patients were included if they exhibited clinical symptoms arising from the PFJ (anterior or retropatellar knee pain 20 severity ≥ 4 on an 11-point numerical pain scale during ≥ two PFJ loading activities: stair ambulation, squatting and rising from sitting; aggravating activities, symptoms present on 22 most days during the past month) and radiographic criteria (Kellgren and weight and body mass index (BMI) were recorded for all subjects. The pain subscale of the Knee Injury and Osteoarthritis Outcome Score (KOOS-pain) was used to score knee 14 osteoarthritis pain 15 .
16
Measurement of quadriceps volume
MR imaging was performed in the supine position on the most symptomatic leg in the PFJ 18 OA group and the dominant leg in the control group. Both knees were fully extended to ensure uniformity of positioning between subjects. The MR images were recorded on a 20
Siemens (Erlangen Germany) 3T Trio MR scanner using a T2-weighted fat-suppressed (water excitation) MEDIC (multi-echo data image combination) gradient echo sequence (TE 22 = 12 ms, TR = 23 ms, NEX = 1, Flip angle 12 degrees, 155Hz/Px, Parallel imaging GRAPPA 2) with a slice thickness of 1 mm isotropic voxels. This sequence was chosen because it was 24 fast and gave reasonable delineation of muscle, cartilage and bone. The in-plane image resolution was 397 x 916 pixels. The number of coronal images ranged from 300 to 400 for 26 7 each participant depending on their height. Acquisition time was approximately 25 minutes 2 per subject.
4
The CSAs of the vastus medialis, vastus lateralis, vastus intermedius and rectus femoris muscles were measured on axial MR images from the origin of the muscle to the insertion by 6 manually digitizing muscle boundaries using commercially available software (Amira 5.2, Visage Imaging, Berlin). For each muscle, the CSAs of each axial slice were summed and the 8 total sum of the muscle CSAs was then multiplied by the slice thickness to obtain the muscle volume ( Fig 1A) . For each participant, the CSAs of the vastus medialis and vastus lateralis 10 were recorded at ten evenly spaced levels from the femoral condyles through to the lesser trochanter ( Fig 1B) . 12
16
The intra-rater reliability of the muscle volume measurement technique was quantified in nine randomly selected subjects ( 18, SPSS Inc., Chicago, IL) and α < 0.05. Between-group differences in participant characteristics were assessed using independent t-tests or chi square tests as appropriate. The 4 ratio of vastus medialis to vastus lateralis (VM/VL) muscle volume was calculated for both the control and PFJ OA groups. To control for the influence of body weight and gender, 6 muscle volumes (cm 3 .kg -1 ) were normalized to body weight and all between-group comparisons of muscle volumes were performed using an Analysis of Covariance (with and 8 without gender as a covariate). Radiographic disease severity and knee pain are also potential confounders, and the univariate association of radiographic disease severity of the PFJ 10
(measured with the KL grading system 14 ) and the KOOS-pain subscale with the individual muscle volumes was determined using the Spearman's rho correlation coefficient. Regression 12 analyses were performed on the ten equally-spaced CSAs (from the femoral condyles to lesser trochanter of the femur) of vastus medialis and vastus lateralis to determine the CSA 14 that best predicted the muscle volume in the control and PFJ OA groups. To evaluate whether dominance influenced vasti muscle size, the CSA that best represented the medial and lateral 16 vasti was also calculated for the non-dominant leg of the control group, and these were compared to the dominant leg using a paired t-test. 18
RESULTS
20
Participant and disease characteristics
The control group (n = 11; age 53 ± 5 years, body weight 71 ± 14 kg, BMI 25 ± 3 kg.m -2 ) and 22 the PFJ OA group (n = 22; age 57 ± 11 years, weight 77 ± 13 kg, BMI 27 ± 4 kg.m -2 ) were matched for all participant characteristics (p > 0.05). There were more females than males in 24 both groups (female: male ratios in the control and PFJ OA groups were 7:4 and 15:7, respectively), with no difference in the frequencies (χ² = 0.546; p-value = 0.07). No 
16
Relationship between vastus medialis and lateralis volumes and cross-sectional areas
Comparison of muscle size between dominant and non-dominant limbs 26
For the vastus medialis, the CSA at the 3 rd level of the dominant leg (20 ± 6 cm 2 ) was not 2 significantly different from the non-dominant leg (21 ± 7 cm 2 ); p = 0.161. Similarly, for the vastus lateralis there was no significant difference between the CSA at the 7 th level for the 4 dominant leg (28 ± 5 cm 2 ) and the non-dominant leg (27 ± 6 cm 2 ); p = 0.184.
6
DISCUSSION
The volumes of the vastus medialis and vastus lateralis, normalized to body weight, were 8 significantly smaller in the PFJ OA group (approximately 20%) than the control group.
However, we found no difference in the ratio of VM/VL volumes between those with and 10 without PFJ OA. In both the PFJ OA and the control group, the ratio of VM/VL was approximately 0.67, indicating that the vastus medialis volume was approximately 2/3 that of 12 the vastus lateralis in both groups. Based on the evidence from cadaveric and modeling studies, indicating that imbalance of the medial and lateral vasti contributes to heightened 14 lateral PFJ stress 16, 17 , we considered that there may have been a lower ratio of VM/VL volumes in those with PFJ OA. Our finding of no difference in the VM/VL ratio implies that 16 the force generating capacity of the vastus medialis is not affected to a greater extent than that of the vastus lateralis in our population with PFJ OA. 18
While we did not observe between-group differences in the relative muscle volume between 20 the two heads of the vasti, it is possible that altered coordination and activation of the vastus medialis and lateralis may exist in those with PFJ OA. Indeed, modeling studies have 22 identified that delayed activation of the medial quadriceps (relative to the lateral quadriceps) increases lateral patellar malalignment 18, 19 , leading to areas of heightened contact pressure 24 across the lateral PFJ 16, 17 . However, it is also possible that our findings may be more aligned with studies that did not observe differences in the onset timing of the medial and lateral vasti 26 11 between those with and without generalized knee OA [20] [21] [22] . While the current study cannot be 2 compared to those studies that have investigated temporal aspects of the vasti activations in people with generalized knee OA, further investigation is required to establish whether the 4 imbalances in activations of the vasti muscles, observed in younger people with patellofemoral pain 23, 24 , are also a feature of PFJ OA. 6
The finding of lower size in three of the four quadriceps in the PFJ OA group reflects 8 previous reports of association between reduced quadriceps strength and PFJ OA 5, 25 . Muscle weakness is influenced by muscle atrophy and the capacity to fully activate the muscle 4 . 10 Hence, our findings suggest that vastus medialis, vastus lateralis and rectus femoris atrophy may be a feature of PFJ OA and likely contribute to torque deficits observed in these 12
individuals. Smaller quadriceps muscles may have reduced capacity to absorb shock 26 or provide integrated sensorimotor function to the knee joint 27 , thus rendering the joint more 14 susceptible to damage 28 . Furthermore, results from a longitudinal cohort study 5 and an animal model 28 indicate that the PFJ is more susceptible to joint degeneration than the TFJ in the 16 presence of lower quadriceps strength. Due to the cross-sectional nature of our research design it is not possible to determine whether the pain and structural changes associated with 18 PFJ OA leads to muscle disuse and atrophy, or whether reduced muscle activity contributes to PFJ OA onset. However, our findings indicate that a program designed to improve strength 20 in the vastus medialis and vastus lateralis, in addition to the rectus femoris, may benefit those with PFJ OA. However, such programs could also overload the PFJ 29 , with potential to 22 increase pain; thus, progression of load should be carefully managed. Further studies are required to confirm whether quadriceps strengthening could reduce symptoms or disease 24 progression in people with PFJ OA.
12
We used MR imaging to quantify muscle size, which expanded on previous studies that 2 evaluated the strength of the quadriceps when represented as one whole muscle-tendon unit.
Since our study did not detect any imbalance in the relative contributions of the medial and 4 lateral vasti, it is not clear whether measurement of the sizes of the individual quadriceps subregions provides greater value than overall quadriceps strength measures obtained from 6 dynamometry. Furthermore, MR imaging of the entire thigh is expensive and the segmenting of muscle volumes is time-consuming. However, dynamometry is not readily available in the 8 clinical setting, and this instrumentation is expensive to purchase. Our results indicate that CSAs of the VM and VL (at specified levels) may provide a valid indication of muscle size 10 for those clinicians and researchers without access to dynamometry.
Our study highlights that the VM CSA at approximately 8 cm (control) and 12 cm (PFJ OA) above the femoral condyles were the best predictors of VM volume, while VL CSA at 14 approximately 24 cm (control) and 20 cm (PFJ OA) best predicted VL volume. The gross anatomies of the two muscles are quite distinct, which was reflected in the disparate levels 16 that best represent the corresponding muscle volume. Indeed, these levels generally represent the largest CSA for each individual vastus. However, previous studies have described vasti 18 CSA at a single level, with distances ranging from 3.8 cm 8, 9 to 15 cm 10 superior to the proximal patella pole, which may not represent the muscle volumes and force capacities of 20 these muscles. These studies ought to consider the specific CSA of the muscle that is most representative of the muscle's volume, in addition to controlling for the effects of gender and 22 body weight.
24
In the current study, we investigated muscle size for the individual quadriceps components in people with and without symptomatic radiographic PFJ OA. The quantification of muscle 26 13 volume used in the current study provides a better estimate of the force generating capacity of 2 the muscles than measuring anatomical CSAs, which may not be representative of the muscle's PCSA. Our calculations of muscle volume, PCSA and peak isometric force values 4 in the control group (Table 1 and Supplementary Table) were in reasonable agreement with those in the literature [30] [31] [32] . 30 .
12
There are a number of limitations of our study that should be considered. The MR images were performed under non-weight bearing conditions at full knee extension, which is 14 standard protocol for clinical imaging of the knee; however, it is not known whether the results would have been the same if a weight-bearing activity (involving quadriceps 16 activation) was simulated. While these limitations may have influenced the calculations of muscle volume, they are unlikely to have affected the between-group comparisons. The use 18 of the dominant leg to calculate muscle volume in the control group and the most symptomatic leg in the PFJ OA may have resulted in bias. However, we performed some 20 preliminary analyses to confirm that the CSA for vastus medialis and vastus lateralis were not different between legs in the control group. Therefore, it is unlikely that meaningful between-22 leg differences in the control group would have affected our between-group comparisons. A further limitation is the lack of detailed MR data, from which to score additional features of 24 osteoarthritis. For example, the radiographs cannot reveal features such as cartilage or bone marrow lesions, synovitis or effusion. Therefore, we cannot rule out that some participants in 26 14 the control group may have had signs of OA that were not detectable on radiographs. 2 However, currently radiographic definitions of OA remain the gold standard, and we can be confident that our control group was free of radiographically detected OA. 4
It is also acknowledged that neuromuscular factors contribute to a muscle's strength and that 6 the strength and size of other antagonistic or synergistic muscles also influence the load on the PF joint, and therefore may be important for people with PFJ OA. Finally, the cross- lines identify the levels that were the strongest predictors of muscle volume for the controls, whereas the solid gray lines identify the levels that were the strongest predictors of muscle volume for the PFJ OA participants. Figure 1 (Separate file attachment) Table 1 : Averaged muscle volumes of the quadriceps for the PFJ OA and control groups. Muscle volume and muscle volume normalized to subject mass are given, along with standard deviations (SD). Significant differences (p<0.05) in normalized muscle volume between the PFJOA subjects and control subjects are indicated. 
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